Canada’s Cannabis Advantage: Infrastructure, Innovation, and the Road to Global Dominance

At the recent International Cannabis Business Conference (ICBC) Berlin in April, a panel of industry veterans gathered to discuss the evolution and future trajectory of the Canadian cannabis market.

Moderated by Alex Revich, the discussion provided a comprehensive look at how Canada has been actively leveraging its first-mover advantage while navigating the complexities of a maturing and constantly evolving industry.

Marijuana Legalization Is Linked To ‘Significant Reductions’ In Opioid Overdoses, Federally Funded Study Finds

States that legalize medical or recreational marijuana see “significant reductions” in opioid overdoses among adults with employer-sponsored health insurance—indicating that a “substitution” effect may be at play—according to a new federally funded study.

Drug convictions no obstacle to becoming licensed cannabis dealer in Canada

Canadians with past drug convictions are still eligible to become federally licensed cannabis dealers under Ottawa’s regulatory system, according to the Department of Health.

Health Canada Seeks Feedback on Potential Changes to Industrial Hemp Regulations

Health Canada is looking to streamline aspects of the nation’s industrial hemp regulations as part of the government’s red tape reduction efforts.

In a Notice of Intent posted on May 15, 2026, the federal health agency called for interested parties to provide feedback on potential amendments to the Industrial Hemp Regulations (IHR).